Related Experiment Videos
Maternal and amniotic fluid steroids throughout human pregnancy
American Journal of Obstetrics and Gynecology
|July 15, 1979
Summary
Amniotic fluid steroid levels, including testosterone and estradiol, show sex differences before 20 weeks gestation. Elevated levels indicate fetal congenital adrenal hyperplasia or placental issues.
Area of Science:
- Reproductive endocrinology
- Prenatal diagnostics
Background:
- Steroid hormone profiling in pregnancy is crucial for understanding fetal development and identifying potential complications.
- Amniotic fluid and maternal serum provide distinct insights into the endocrine environment during gestation.
Purpose of the Study:
- To measure and compare concentrations of key androgens and progestins in amniotic fluid and maternal blood across gestation.
- To investigate potential sex-based differences in steroid levels during early pregnancy.
- To assess the utility of amniotic fluid steroid analysis in detecting specific fetal and placental conditions.
Main Methods:
- Radioimmunoassay (RIA) was employed to quantify testosterone, dihydrotestosterone, androstenedione, progesterone, 17 alpha-hydroxyprogesterone, and estradiol.
- Samples were collected from normal pregnancies between 14 and 40 weeks of gestation.
- Simultaneous measurements were performed in amniotic fluid and maternal peripheral blood.
Main Results:
- Significant sex differences in amniotic fluid androgen levels (testosterone, dihydrotestosterone, androstenedione) were observed before 20 weeks, with higher concentrations in male pregnancies.
- Elevated amniotic fluid 17 alpha-hydroxyprogesterone was noted in a fetus with congenital adrenal hyperplasia.
- Markedly increased steroid levels in amniotic fluid were found in a pregnancy with molar degeneration of the placenta.
- Maternal peripheral blood dihydrotestosterone also showed a sex difference before 20 weeks, higher in male pregnancies.
- No significant correlation was found between maternal serum and amniotic fluid steroid levels.
Conclusions:
- Amniotic fluid steroid hormone profiles, particularly androgens, exhibit sex-specific patterns in early to mid-gestation.
- Amniotic fluid steroid analysis holds potential for prenatal diagnosis of conditions like congenital adrenal hyperplasia and placental abnormalities.
- Maternal serum steroid levels do not reliably reflect the amniotic fluid steroid milieu during pregnancy.